VIMAP Technologies
VIMAP Technologies is a privately held Spanish medical device manufacturer, founded 2005, that designs and produces patented CO2 insufflators and injectors for CT colonography, pediatric intussusception reduction, and angiography, selling to hospitals and radiology departments across 30+ countries via a global distributor network.
- Company typePrivate
- Founded2005
- HeadquartersAlhaurin de la Torre, Spain
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What VIMAP Technologies does
VIMAP Technologies is a privately held Spanish medical device company founded in 2005 and headquartered in Alhaurin de la Torre near Malaga, Spain, where it operates its own R&D laboratory and manufacturing plant. The company specializes exclusively in the design and production of CO2 insufflators and injectors used in diagnostic imaging and minimally invasive procedures, holding eight international patents covering its core technologies. Its current product portfolio centers on two device families: the VMX-1020A CO2 insufflator for CT colonography (virtual colonoscopy) and pediatric intussusception reduction, and the INX-1000A automatic CO2 injector for arterial and venous angiography, urinary, gastrointestinal, peritoneal, CT and C-Arm contrast, and guided vascular interventions. These are supported by an installed base of legacy VMX-1000A and VMX-1010A units, plus a recurring line of disposable administration sets (AS-3W and IS-IN-LL-A series) and accessories including regional high-pressure hose kits and equipment carts.
The technical differentiators are proprietary and clinically meaningful. The patented Quick Purge System completes an automatic CO2 purge in 1–2 minutes with real-time CO2/air sensing to ensure 100% CO2 before patient injection. The integrated CO2 Heating System warms gas to 48.5°C to relax colon musculature and eliminate the need for Buscopan pre-medication. The VMX-1020A is described as the only device in the world with a constant pressure reduction mode certified for pediatric intussusception reduction, reducing perforation risk, and the platform delivers 1mmHg pressure precision, automatic pressure generation without pre-pressurized tanks, a double hydrophilic filtration system, and an algorithm that adapts insufflation parameters to patient colon cleanliness. The INX-1000A supports both CO2 and iodinated contrast via a 2-way valve, enabling hybrid procedures.
VIMAP sells through a global authorized distributor network covering 30+ countries including the UK, France, Italy, Spain, Belgium, Germany, UAE, Saudi Arabia, Singapore, Hong Kong, Thailand, South Africa, and Canada, supplemented by a direct B2B servicing portal. Pricing is quote-based and not publicly disclosed, and the revenue mix combines capital equipment sales, recurring consumables (disposable administration sets), and accessories. The company has accumulated 690 devices deployed globally (234 VMX-1020A, 17 INX-1000A, 327 VMX-1010A, 112 VMX-1000A) and has held CE marking via Spain's AEMPS regulator. End customers are hospitals, radiology departments, and pediatric healthcare facilities, with a secondary persona of patients who cannot receive iodine-based contrast due to allergies or renal insufficiency.
VIMAP Technologies firmographics
Firmographics- Name
- VIMAP Technologies
- Legal name
- VIMAP TECHNOLOGIES
- Website
- https://vimap-medical.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- VIMAP Technologies is a privately held Spanish medical device manufacturer, founded 2005, that designs and produces patented CO2 insufflators and injectors for CT colonography, pediatric intussusception reduction, and angiography, selling to hospitals and radiology departments across 30+ countries via a global distributor network.
- Ownership category
- akta.pro rank
Where VIMAP Technologies is headquartered
LocationHeadquarters
- HQ city
- Alhaurin de la Torre
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
VIMAP Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Hardware Sales: Sale of CO2 insufflators (VMX-1020A, VMX-1010A, VMX-1000A) and CO2 injectors (INX-1000A) as capital equipment to hospitals and medical facilities.
- Consumables and Disposables: Recurring sales of administration sets, disposables, and consumables for the insufflators and injectors. Products include AS-3W-H-R35A, AS-3W-H-R35B, AS-3W-Y-R35A, AS-3W-R35A, and IS-IN-LL-A series.
- Accessories: Sale of accessories including carts, USB controls, high-pressure hoses (REGH-KIT series), and other supporting equipment.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Medical device pricing based on specific equipment model and configuration |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels3 records
VIMAP Technologies product offering
Product offeringCore offering
VIMAP Technologies designs, manufactures, and sells proprietary CO2 insufflators (VMX series) and CO2 injectors (INX series) for medical imaging procedures including CT colonography, pediatric intussusception reduction, and CO2 angiography. The company controls the entire production cycle from R&D to manufacturing at its facility in Spain, supported by 8 international patents covering its devices and disposable administration sets.
Product overview
VIMAP Technologies offers a specialized portfolio of CO2 medical devices focused on insufflation and injection technologies. The product line centers on two core device families: the VMX-1020A CO2 Insufflator for virtual colonoscopy and pediatric intussusception reduction, and the INX-1000A CO2 Injector for angiography and vascular interventions. Both devices are supported by a comprehensive range of disposable administration sets (AS-Series for insufflators, IS-Series for injectors) and accessories including carts and high-pressure hoses. The company maintains complete control over design and manufacturing in Spain, holding eight international patents for its medical devices and consumables.
Differentiator
Problem solved
Functional benefit
Brands
- VMX Series CO2 Insufflators: CO2 insufflators for virtual colonoscopy (CTC) and intussusception reduction for children
- INX Series CO2 Injectors
Products and services
- VMX-1020A CO2 Insufflator
- INX-1000A CO2 Injector
- AS-3W-H-R35A Disposable Administration Set
- AS-3W-H-R35B Disposable Administration Set
- IS-IN-LL-A Disposable Administration Set
- ACC-VMX1020A-KIT001 Accessory Kit Accessory kit for VMX-1020A including 2 ballast bags to hold the heating hose on the patient stretcher, tightening keys, and instruction manual.
- CAR-XXXXD Cart Cart for easily moving the apparatus, storing gas cylinders and consumables. Specifically designed for INX-1000A.
- REGH-KIT High-Pressure Flexible Hoses High-pressure flexible hoses available in multiple standards: TYPE C DIN477-1 (France, Germany, Spain), CGA940 PIN INDEX (Asia, Canada, South Africa, UK), W27x2-ISO5145 (Italy, Norway), UNF7/16-UNF7/16 (Czech Republic).
- VMX-1010A CO2 Insufflator Earlier-generation CO2 insufflator model from VIMAP's product range, deployed globally with 327 units in use across hospitals and radiology departments.
- VMX-1000A CO2 Insufflator Earlier-generation CO2 insufflator model from VIMAP's product range, deployed globally with 112 units in use across hospitals and radiology departments.
Quantifiable outcome
- Up to 50% less pressure required for intussusception reduction compared to intermittent methods
- +3 more outcomes
Companies that use VIMAP Technologies
Customer profileSegments3 records
Ideal customer profiles2 records
VIMAP Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
VIMAP Technologies partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
VIMAP Technologies competitors and assessment
Company assessmentBroad incumbents
- Philips Healthcare: Philips Healthcare produces CT, angiography, and interventional imaging systems that are paired with VIMAP's CO2 delivery devices in procedure suites. It competes indirectly as a comprehensive imaging vendor in the same hospital procurement decisions.
- Hologic: Hologic is a women's health and imaging company whose CT and mammography systems integrate with CT colonography workflows. While Hologic does not make CO2 insufflators directly, it competes in the broader CT colonography market where VIMAP's VMX-1020A is used.
- Bracco Imaging: Bracco is a major contrast media and imaging solutions company that competes broadly in the imaging procedure space where VIMAP operates. While Bracco's portfolio centers on iodinated contrast agents, its presence in CT colonography and angiography overlaps with VIMAP's target procedures.
- Medtronic: Medtronic is a broad medical device incumbent with endoscopy, imaging, and interventional product lines that overlap procedurally with VIMAP's use cases. Its scale and resources make it a relevant comparator for the long-term competitive landscape in imaging-guided procedures.
- Boston Scientific: Boston Scientific manufactures interventional and endoscopy devices used in similar hospital departments as VIMAP's products. While not a direct CO2 insufflator competitor, it competes for the same hospital budgets and procedure volumes in minimally invasive imaging-guided interventions.
- Siemens Healthineers: Siemens Healthineers supplies CT, angiography, and C-Arm systems used alongside VIMAP's devices. It is a broad incumbent in the imaging equipment space where VIMAP's consumables and injectors are deployed.
- GE HealthCare: GE HealthCare is a dominant imaging equipment vendor (CT scanners, C-Arms) used in the same radiology and interventional suites where VIMAP's insufflators and injectors operate. It does not compete directly in CO2 delivery but shapes the procedure ecosystem.
Direct peers
- AngioDynamics: AngioDynamics manufactures vascular access and interventional medical devices, including products for CO2 angiography and peripheral vascular procedures. It directly competes with VIMAP's INX-1000A injector in vascular imaging and interventional radiology markets.
- Merit Medical Systems: Merit Medical manufactures angiography and interventional devices, including contrast management and injection systems used in radiology suites. It serves the same hospital customers as VIMAP with overlapping products for imaging-guided procedures.
- Guerbet: Guerbet (which acquired E-Z-EM, the historical leader in CO2 angiography delivery systems) is a direct peer in CO2-based contrast delivery for vascular and imaging procedures. Both companies serve radiology departments with CO2 delivery technology, making Guerbet the closest comparable in VIMAP's core market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
VIMAP Technologies social profiles
Digital presenceVIMAP Technologies compliance and trust
Trust signalCompliance1 record
VIMAP Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
VIMAP Technologies leadership team
Management profileNumber of profiles
VIMAP Technologies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VIMAP Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VIMAP Technologies
What does VIMAP Technologies do?
VIMAP Technologies designs, manufactures, and sells proprietary CO2 insufflators (VMX series) and CO2 injectors (INX series) for medical imaging procedures including CT colonography, pediatric intussusception reduction, and CO2 angiography. The company controls the entire production cycle from R&D to manufacturing at its facility in Spain, supported by 8 international patents covering its devices and disposable administration sets.
Is VIMAP Technologies a public or private company?
VIMAP Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was VIMAP Technologies founded?
VIMAP Technologies was founded in 2005. It employs 1 to 10 people.
Where is VIMAP Technologies based?
VIMAP Technologies is headquartered in Alhaurin de la Torre, Spain, in the Europe region.
How does VIMAP Technologies make money?
Three revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are consumables and Disposables and accessories.
Who are VIMAP Technologies's main competitors?
Broad incumbents on record are Philips Healthcare, Hologic, Bracco Imaging, Medtronic, Boston Scientific, Siemens Healthineers and GE HealthCare. Direct peers are AngioDynamics, Merit Medical Systems and Guerbet.
Does VIMAP Technologies have an API?
No public API is recorded for VIMAP Technologies.